CAMP vs NWSA · rev $3.5M vs rev $9.03B
CAMP4 THERAPEUTICS CORPORATION (CAMP) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
NWSA (NWSA) common stock.
Latest reported CAMP revenue for 2025-12-31 was $3.5M. Net income was -$80.4M. Revenue was up 436.5% from 2024-12-31 to 2025-12-31. CAMP currently screens at market cap $215.0M.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
CAMP currently screens at market cap $215.0M. NWSA currently screens at market cap $0.
Not investment advice. Open the CAMP and NWSA stock pages for the full models.
Not investment advice.